Applying machine learning to a large BC dataset reveals a subset of ER+Her2‐ tumors (pseudomutant p53 tumors) which, despite retaining wt p53, display gene expression and pathway deregulation profiles typical of p53‐mutated tumors, correlating with bad prognosis. Here, ERBB2 is linked to breast cancer.